English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Carol Ostrow | Nov 16, 2017

STORM Therapeutics names Institute of Cancer Research CEO to board

Carol Ostrow | Nov 16, 2017

European study demonstrates economic benefits of Tresiba

Marian Johns | Nov 16, 2017

Patient groups say Orphan Drug Tax Credit repeal could result in fewer treatments for rare diseases

Marian Johns | Nov 16, 2017

Scientists call for more clinical studies of nonchemotherapy drugs

Kathy Adams | Nov 16, 2017

Philadelphia Insurance Companies sponsors American Diabetes Association camp program

Kathy Adams | Nov 15, 2017

AbbVie executive to present at Jefferies London Healthcare Conference

Carol Ostrow | Nov 11, 2017

Vanderbilt developing local HIV prevention program

Carol Ostrow | Nov 11, 2017

New York family welcomes quads on Halloween

Trending

+ Pharmaceuticals
Patient Daily | Sep 23, 2025

Wall Street Journal editorial board alleges hospitals misuse 340B program

+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Nurses United for Healthcare Integrity says hospitals abuse 340B drug pricing program

+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Staff Attorney of Legal Aid Society on 340B: 'Hospitals are exploiting the 340B program'

Patient Daily | Sep 19, 2025

ENT specialist on ongoing chronic sinus cases: ‘Some of it could be incomplete surgery’

  • « First
  • «
  • …
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily